Biotech news
Americas
The US Supreme Court has agreed to hear the biosimilars dispute between Amgen and Sandoz. 16 January 2017
Americas
Pharmaceutical research company Phigenix lost an appeal at the US Court of Appeals for the Federal Circuit yesterday, after the court found that the company lacked standing in a patent case against ImmunoGen. 10 January 2017
Biotech
Several changes have been made to Italy’s regulatory landscape for biosimilars, as Luca Tosoni of Covington & Burling reports. 10 January 2017
Americas
Sanofi and Regeneron Pharmaceuticals have revealed plans to appeal against an injunction granted to Amgen, which prevents the companies from selling cholesterol-lowering medicine Praluent. 9 January 2017
Americas
Sanofi and Regeneron Pharmaceuticals must stop selling cholesterol-lowering medicine Praluent after Amgen obtained an injunction against the companies. 6 January 2017
Biotech
The English High Court has dismissed an application for summary judgment from pharmaceutical company AbbVie. 6 January 2017
Americas
US-based law firm Offit Kurman has boosted its expertise in Virginia with the appointment of Christopher Raimund as a principal in the intellectual property practice. 5 January 2017
Americas
Amgen secured victory yesterday as a US federal judge refused to throw out a ruling upholding the validity of two patents owned by the company. 4 January 2017
Americas
Pfizer has agreed a collaboration and licensing agreement with Sweden-based pharmaceutical company BioInvent International on cancer immunotherapy research. 22 December 2016
Pharma
A combination of patents, SPCs and regulatory exclusivities should be considered carefully in order to maximise the exclusivity available for cell therapies, as Glyn Truscott of Elkington + Fife explains. 22 December 2016